Background-Angiotensin (Ang) II, a major regulatory factor for left ventricular mass, is generated from Ang I by ACE.
A ngiotensin II (Ang II) is a potent vasoconstrictor and stimulator for cell growth. Ang II also plays a major role in the pathogenesis of hypertension, intimal hyperplasia, and cardiac hypertrophy. [1] [2] [3] [4] Ang II is generated from Ang I by ACE. An insertion/deletion (I/D) polymorphism of intron 16 of the ACE gene is related to plasma and tissue ACE levels. 5 Individuals who are homozygous for the deletion (DD) exhibit higher circulating and tissue levels of ACE than individuals who are homozygous for the insertion (II) or who are heterozygous (ID). The variance of ACE density among the 3 genotypes may generate diverse Ang II production.
In the present study, we examined the possible influences of the ACE genotype on heart weight and found it was a predictor of heart weight; however, it was less effective than epigenetic factors such as hypertension or age.
Methods

Subjects
From 693 consecutive patients autopsied between 1994 and 1998 in Tokyo Metropolitan Geriatric Hospital with written consent by the patient and/or families under the Act of Postmortem Examination, 226 patients with myocardial infarction, valvular heart disease, or cardiomyopathy and 24 patients whose data were incomplete were excluded. The remaining 443 patients (208 females and 235 males) were the subjects of the present study. A history of hypertension, diabetes mellitus, or hypercholesterolemia (Ͼ220 mg/dL) was sought in the medical records.
DNA Purification and Determination of ACE Genotype
Genomic DNA purification from frozen kidney tissue and determination of ACE genotypes by polymerase chain reaction were performed according to standard methods. 6 Amplification products were analyzed on a 2% agarose gel.
Heart Weight
Body weight, height, and heart weight were obtained at autopsy. To standardize the individual heart, the heart weight was corrected for body surface area (BSA). The BSA was calculated according to DuBois' formula: weight 0.425 ϫheight 0.725 ϫ71.84. The corrected heart weight was expressed as g/m 2 .
Coronary Stenosis Index
Coronary arteries were cut every 5 mm, and each section was examined and its degree of stenosis scored. The stenosis was expressed as a range from 0 to 5 as follows: 5, 100% or 99% stenosis; 4.5, 90% stenosis; 4, 75% stenosis; 3, 50% stenosis; 2, 25% stenosis; 1, minimal change; and 0, no stenosis. The coronary stenosis index (CSI) was defined as the sum of the value of the maximum stenosis of each of the 3 vessels examined. The CSI ranged from 0 to 15.
Statistical Analysis
Observed frequencies of the 3 ACE genotypes were compared with predicted frequencies based on Hardy-Weinberg equilibrium. Other statistical analysis was performed with StatView 4.5 for Macintosh. The 2 test was used for comparison of genotype distribution of sex, hypertension, diabetes mellitus, and hypercholesterolemia. Mean age, BSA, CSI, and corrected heart weight between groups were compared by 1-way ANOVA, and the results were assessed by Fisher's exact test. For multiple regression analysis, subjects with a history of hypertension were scored as 1 and those without hypertension as 0; DD genotype was scored as 1, and ID or II genotype was scored as 0. The results were considered statistically significant at PϽ0.05.
Results
Among 443 patients, 51 were homozygous for the deletion (DD), 184 were heterozygous (ID), and 208 were homozygous for the insertion (II). The observed frequency distribution of ACE genotypes did not deviate from that predicted (46.2, 193.7, and 203.2, respectively) by Hardy-Weinberg equilibrium ( 2 ϭ1.107, PϾ0.20). There were no significant differences in sex, BSA, history of hypertension, or history of hypercholesterolemia among the 3 ACE genotype groups. Diabetes mellitus was significantly less frequent in the II genotype. The CSI was greater for the DD genotype, but this difference was not statistically significant (Table 1) .
Heart weight was 249.9Ϯ49.9 g/m 2 for patients with the DD genotype, 230.0Ϯ51.2 g/m 2 for the ID genotype, and 226.8Ϯ49.8 g/m 2 for the II genotype. Hearts in the DD group were significantly heavier than those in the other 2 groups (PϽ0.05 versus ID; PϽ0.01 versus II). There was no significant difference between the ID and II genotypes (Figure 1 ). We divided all subjects into 2 groups, with or without hypertension. In the normotensive group, there was no obvious difference in heart weight among the 3 genotypes. On the other hand, in the hypertensive group, a significant difference in heart weight was seen between the DD and II genotypes (266.3Ϯ52.1 versus 238.0Ϯ52.2 g/m 2 , respectively; PϽ0.05) (Figure 2) .
The average heart weight in the hypertensive group was 246.8Ϯ52.8 g/m 2 , which is Ϸ30 g/m 2 heavier than that in the normotensive group (217.4Ϯ44.9 g/m 2 ; PϽ0.0001) ( Table 2 ). The heart weight in the DD group was 247.9Ϯ49.5 g/m 2 , and that in the non-DD (DI and II) group was 228.3Ϯ50.5 g/m 2 . Hearts of patients in the DD group were Ϸ20 g/m 2 heavier than those of patients in the ID and II groups (PϽ0.01) ( Table  2 ). There was no relation between heart weight and sex, diabetes mellitus, or hypercholesterolemia (Table 2) .
Simple regression analysis was performed between heart weight, CSI, and age (Table 3) . These 3 factors are interrelated, with some difference in correlation coefficients.
To analyze the relative contribution of each of these factors to heart weight, we performed multiple regression analysis Heart weight of each ACE genotype was analyzed in subgroups with and without history of hypertension. In normotensive subgroup, there was no significant heart weight difference among 3 genotypes. In hypertensive subgroup, difference of heart weight was prominent. Heart weights were as follows: normotensive subgroup, DD 227.1Ϯ37. 5 
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using the factors that were positively related in simple regression analysis: history of hypertension, DD genotype, age, and CSI. History of hypertension (PϽ0.0001) and age (Pϭ0.0001) were strong predictors of heart weight. The DD genotype was also an independent predictor of heart weight (Pϭ0.0154). There was no relation between CSI and heart weight (Pϭ0.1389).
Discussion
These studies indicate that there is a relationship between ACE genotype and heart weight. Hearts of patients with the DD genotype were significantly heavier than those of patients with the ID and II genotypes. For cardiac muscle mass, the ACE genotype was a less effective determinant than epigenetic factors such as hypertension or age. Our subjects were taken from consecutive autopsies in a general hospital for the aged and were not limited to certain medical specialities. Hence, these patients reflect the general population in Japan. The frequencies of the DD, ID, and II genotypes were 11.5%, 41.5%, and 47.0%, respectively. The prevalence of the D allele was 32.3%. These values are comparable to those of previous reports on Asian people. [7] [8] [9] The renin-angiotensin system plays a major role in mediating left ventricular hypertrophy and cell growth. [2] [3] [4] This effect is thought to be caused by Ang II 1 generated from Ang I. Although Ang II is also produced by enzymes other than ACE, such as chymase, 10, 11 ACE is thought to be an important enzyme for the production of Ang II.
Circulating ACE activity has been reported to differ in the 3 ACE genotypes by unknown mechanisms. 5 This diverse ACE activity may result in diverse Ang II concentrations and hence variations in left ventricular mass. 12 However, there is a lack of agreement about the relation of the ACE polymorphism and left ventricular hypertrophy. [13] [14] [15] [16] There are several reasons for this disagreement. First, the relationship between ACE genotypes and heart weight may not be conspicuous enough to be specified above the background noise level. Second, there is no way to precisely measure heart weight or left ventricular weight/mass except at autopsy. Left ventricular mass is usually estimated indirectly by echocardiography or angiography. 13, 14 A history of hypertension was the most effective predictor of heart weight ( Figure 2 ), which suggests that mechanical stress may be a major factor in the regulation of cardiac muscle mass. Hemodynamic stimulation causes autocrine release of Ang II from cardiac myocytes, [2] [3] [4] activates signal transduction through receptors in myocytes, and triggers myocardial hypertrophy. 17, 18 There was a prominent difference in heart weight between the DD and II genotypes in the hypertensive group, whereas there was no statistical difference between genotypes in the normotensive group (Figure 2) . The observed heart weight difference by genotype is apparently triggered by high blood pressure. 19 The effect of ACE genotype on left ventricular muscle mass seems to be enhanced by stimulation, such as physical training, 20 hemodialysis, 21 and myocardial ischemia. 22 Another less plausible explanation is that ACE genotype is related to the severity of hypertension. Unfortunately, data regarding the severity of hypertension in our patient population were not available. In most studies, the relation between hypertension and ACE genotype has been negative. [23] [24] [25] [26] Although the relation between CSI and heart weight was negative on multiple regression analysis, it is difficult to reject such a relation, because the 3 factors examined (age, history of hypertension, and CSI) were closely correlated. Because patients with myocardial infarction were not included in our study, the role of ischemia in heart weight remains to be elucidated.
Diabetes mellitus was less frequent in the II genotype (Table 1) . There is a report that patients with non-insulindependent diabetes mellitus who have the DD genotype have higher blood glucose levels and are more glucose intolerant. 27 Our results may be comparable to this.
In conclusion, these studies demonstrate that the ACE genotype was a predictor of heart weight, although it was less effective than epigenetic factors such as hypertension or age. The association between ACE genotype and left ventricular mass had been conflicting. Our findings provide new evidence that the ACE gene polymorphism plays a detectable role in the structure of heart mass. 
